NCT07173621View on ClinicalTrials.gov

Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Operative Healing in Patients Who Have Undergone Thyroid and Parathyroid Surgery Via the Transcutaneous Approach

NAEnrolling by invitationINTERVENTIONAL

Enrollment

334

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2027

Conditions

Thyroid; WoundParathyroid DiseasesSurgical IncisionIncision

Interventions

OTHER

Amnioeffect

Amnioeffect is a placental-based allograft made of lyophilized human amnion/intermediate/chorion membrane (LHACM)

Trial Locations (1)

34239

Sarasota Memorial Health Care System, Sarasota

All Listed Sponsors

collaborator

MiMedx Group, Inc.

INDUSTRY

lead

Sarasota Memorial Health Care System

OTHER

NCT07173621 - Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Operative Healing in Patients Who Have Undergone Thyroid and Parathyroid Surgery Via the Transcutaneous Approach | Biotech Hunter | Biotech Hunter